Literature DB >> 24315093

Autophagy-mediated tumor promotion.

Jessie Yanxiang Guo1, Bing Xia, Eileen White.   

Abstract

Mouse models for cancer are revealing novel cancer-promoting roles for autophagy. Autophagy promotes tumor growth by suppressing the p53 response, maintaining mitochondrial function, sustaining metabolic homeostasis and survival in stress, and preventing diversion of tumor progression to benign oncocytomas.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24315093      PMCID： PMC3987898          DOI： 10.1016/j.cell.2013.11.019

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  25 in total

Review 1.  Autophagy: renovation of cells and tissues.

Authors:  Noboru Mizushima; Masaaki Komatsu
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 2.  Deconvoluting the context-dependent role for autophagy in cancer.

Authors:  Eileen White
Journal:  Nat Rev Cancer       Date:  2012-04-26       Impact factor: 60.716

3.  Autophagy suppresses tumor progression by limiting chromosomal instability.

Authors:  Robin Mathew; Sameera Kongara; Brian Beaudoin; Cristina M Karp; Kevin Bray; Kurt Degenhardt; Guanghua Chen; Shengkan Jin; Eileen White
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

4.  Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.

Authors:  Yanying Huo; Hong Cai; Irina Teplova; Christian Bowman-Colin; Guanghua Chen; Sandy Price; Nicola Barnard; Shridar Ganesan; Vassiliki Karantza; Eileen White; Bing Xia
Journal:  Cancer Discov       Date:  2013-05-06       Impact factor: 39.397

5.  Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses.

Authors:  Daniela Kenzelmann Broz; Stephano Spano Mello; Kathryn T Bieging; Dadi Jiang; Rachel L Dusek; Colleen A Brady; Arend Sidow; Laura D Attardi
Journal:  Genes Dev       Date:  2013-05-01       Impact factor: 11.361

Review 6.  Learning from oncocytic tumors: Why choose inefficient mitochondria?

Authors:  Giuseppe Gasparre; Giovanni Romeo; Michela Rugolo; Anna Maria Porcelli
Journal:  Biochim Biophys Acta       Date:  2010-08-21

7.  Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis.

Authors:  Jessie Yanxiang Guo; Gizem Karsli-Uzunbas; Robin Mathew; Seena C Aisner; Jurre J Kamphorst; Anne M Strohecker; Guanghua Chen; Sandy Price; Wenyun Lu; Xin Teng; Eric Snyder; Urmila Santanam; Robert S Dipaola; Tyler Jacks; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

8.  PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function.

Authors:  Jianglin Ma; Hong Cai; Tongde Wu; Bijan Sobhian; Yanying Huo; Allen Alcivar; Monal Mehta; Ka Lung Cheung; Shridar Ganesan; Ah-Ng Tony Kong; Donna D Zhang; Bing Xia
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

9.  DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.

Authors:  Diane Crighton; Simon Wilkinson; Jim O'Prey; Nelofer Syed; Paul Smith; Paul R Harrison; Milena Gasco; Ornella Garrone; Tim Crook; Kevin M Ryan
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

10.  BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.

Authors:  Chiara Gorrini; Pegah S Baniasadi; Isaac S Harris; Jennifer Silvester; Satoshi Inoue; Bryan Snow; Purna A Joshi; Andrew Wakeham; Sam D Molyneux; Bernard Martin; Peter Bouwman; David W Cescon; Andrew J Elia; Zoe Winterton-Perks; Jennifer Cruickshank; Dirk Brenner; Alan Tseng; Melinda Musgrave; Hal K Berman; Rama Khokha; Jos Jonkers; Tak W Mak; Mona L Gauthier
Journal:  J Exp Med       Date:  2013-07-15       Impact factor: 14.307
View more
  204 in total

1.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

Review 2.  Autophagy, Metabolism, and Cancer.

Authors:  Eileen White; Janice M Mehnert; Chang S Chan
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

3.  Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression.

Authors:  Wenjun Xiao; Bo Dai; Yao Zhu; Dingwei Ye
Journal:  Tumour Biol       Date:  2015-12-05

4.  A PINK1-mediated mitophagy pathway decides the fate of tumors-to be benign or malignant?

Authors:  Hui Qian; Xiaojuan Chao; Wen-Xing Ding
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

5.  New Phage Display-Isolated Heptapeptide Recognizing the Regulatory Carboxy-Terminal Domain of Human Tumour Protein p53.

Authors:  Sihem Ben Abid; Mouna Sahnoun; Ines Yacoubi-Hadj Amor; Salma Abdelmoula-Souissi; Hajer Hassairi; Raja Mokdad-Gargouri; Ali Gargouri
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

6.  Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis.

Authors:  H Helen Lin; Yiyin Chung; Chun-Ting Cheng; Ching Ouyang; Yong Fu; Ching-Ying Kuo; Kevin K Chi; Maryam Sadeghi; Peiguo Chu; Hsing-Jien Kung; Chien-Feng Li; Kirsten H Limesand; David K Ann
Journal:  Autophagy       Date:  2018-08-21       Impact factor: 16.016

Review 7.  Targeting autophagy in skin diseases.

Authors:  Teng Yu; Joshua Zuber; Jinchao Li
Journal:  J Mol Med (Berl)       Date:  2014-11-19       Impact factor: 4.599

Review 8.  Development of autophagy inducers in clinical medicine.

Authors:  Beth Levine; Milton Packer; Patrice Codogno
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

Review 9.  Metabolic control of autophagy.

Authors:  Lorenzo Galluzzi; Federico Pietrocola; Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

10.  Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer.

Authors:  Huiyu Ren; Nicole A Bakas; Mitchell Vamos; Apirat Chaikuad; Allison S Limpert; Carina D Wimer; Sonja N Brun; Lester J Lambert; Lutz Tautz; Maria Celeridad; Douglas J Sheffler; Stefan Knapp; Reuben J Shaw; Nicholas D P Cosford
Journal:  J Med Chem       Date:  2020-11-17       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.